Gemini Therapeutics
Innovative therapies targeting genetically defined subpopulations in dry AMD and related diseases. Learn more
Launch date
Employees
Market cap
$304m
Enterprise valuation
$217m (Public information from Jan 2023)
Share price
$25 GMTX
Cambridge Massachusetts (HQ)
Authorizing premium user...